IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | -100.0% | 66 | -99.9% | 0.00% | -100.0% |
| Q1 2019 | $10,346,000 | +58.0% | 127,457 | +5.2% | 1.20% | +30.6% |
| Q4 2018 | $6,548,000 | +42.5% | 121,117 | +35.9% | 0.92% | +63.7% |
| Q3 2018 | $4,596,000 | +23.8% | 89,100 | 0.0% | 0.56% | +12.2% |
| Q2 2018 | $3,713,000 | -70.4% | 89,100 | -68.6% | 0.50% | -71.7% |
| Q1 2018 | $12,523,000 | -3.9% | 284,100 | +9.6% | 1.76% | -37.6% |
| Q4 2017 | $13,033,000 | -0.7% | 259,100 | +0.0% | 2.82% | +7.0% |
| Q3 2017 | $13,131,000 | -0.3% | 259,000 | 0.0% | 2.63% | -3.6% |
| Q2 2017 | $13,175,000 | +26.5% | 259,000 | 0.0% | 2.73% | +21.5% |
| Q1 2017 | $10,412,000 | -16.0% | 259,000 | 0.0% | 2.25% | -18.3% |
| Q4 2016 | $12,388,000 | +30.5% | 259,000 | 0.0% | 2.75% | +31.6% |
| Q3 2016 | $9,490,000 | +67.4% | 259,000 | +85.0% | 2.09% | +75.9% |
| Q1 2016 | $5,670,000 | +205.2% | 140,000 | +600.0% | 1.19% | +218.5% |
| Q4 2015 | $1,858,000 | – | 20,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
| Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
| BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
| Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
| Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
| Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
| Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
| SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
| HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
| BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |